182 related articles for article (PubMed ID: 21602260)
1. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
[TBL] [Abstract][Full Text] [Related]
5. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count.
Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
BMC Cancer; 2019 Nov; 19(1):1049. PubMed ID: 31694577
[TBL] [Abstract][Full Text] [Related]
9. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
10. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
[TBL] [Abstract][Full Text] [Related]
11. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Tumor Associated Macrophage Markers CD163 and CD68 Immunohistochemistry in Classical Hodgkin Lymphoma.
Rashed RA; Zaki MAM; Mohamed NAW; Mansou OM; Refaey FAHE
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978358
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
15. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.
Koh YW; Park CS; Yoon DH; Suh C; Huh J
PLoS One; 2014; 9(1):e87066. PubMed ID: 24489836
[TBL] [Abstract][Full Text] [Related]
16. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
[TBL] [Abstract][Full Text] [Related]
18. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.
Sánchez-Espiridión B; Martin-Moreno AM; Montalbán C; Medeiros LJ; Vega F; Younes A; Piris MA; Garcia JF
Haematologica; 2012 Jul; 97(7):1080-4. PubMed ID: 22315492
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
Barros MH; Hassan R; Niedobitek G
Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
